Michael Kyba
Michael Kyba is an expert in Biochemistry at University of Minnesota (United States). Michael Kyba has authored 215 publications, the most recent in 2026. SLR score: 1,206 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties: Genetics - Oncology - Rheumatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2002 - 2026
Number : 215
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Elevated mitochondrial Ca 2+ impairs satellite cell pool expansion in response to skeletal muscle injury. PMID 42349424 — cells, muscles, respiration, mitochondria, stem cells, calcium, muscle, skeletal, transplantation | Stem Cell Reports | 2026 | 0 |
| Lipid nanoparticle delivery of antisense gapmers attenuates pathology in a mouse model of facioscapulohumeral muscular dystrophy. PMID 42198843 — injections, muscular dystrophies, safety, muscles, nanoparticles, pathology, muscular dystrophy, facioscapulohumeral, therapeutics, muscle, skeletal, lipid nanoparticles | Mol Ther | 2026 | 0 |
| Modeling CIC::DUX4 sarcoma reveals oncogene-mediated MHCI-dependent immune evasion. PMID 41299516 — oncogenes, cells, neoplasms, sarcoma, therapeutics, immune evasion | Mol Cancer Top journal | 2025 | 0 |
| Estrogen Receptor Regulates Male Satellite Cells in a Female, but Not Male, Environment. PMID 41148825 — cells, estrogens, receptors, estrogen, muscle, skeletal, environment, gonadal steroid hormones, transplantation | Cells | 2025 | 0 |
| Matrix metalloproteinases are hallmark early biomarkers and therapeutic targets in FSHD. PMID 40966415 — muscles, macrophages, biomarkers, matrix metalloproteinase inhibitors, matrix metalloproteinases, therapeutics, metalloproteases | JCI Insight | 2025 | 0 |
LeadR Networks
Main global connection map